Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: Data from 3 health plans

Journal of Infectious Diseases

Volumn 184, Issue 6, 2001, Pages 665-670

  Nordin, James ^a   Mullooly, John ^c   Poblete, Sung ^d   Strikas, Raymond ^e   Petrucci, Richard ^d   Wei, Feifei ^a   Rush, Bill ^a   Safirstein, Benjamin ^d   Wheeler, Deborah ^d   Nichol, Kristin L ^b  

^a HEALTHPARTNERS INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c KAISER PERMANENTE   (United States)

^d 4Oxford Health Plans ^*  (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

AGED; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; PRIORITY JOURNAL; RISK ASSESSMENT; VIRUS PNEUMONIA;

AGE FACTORS; AGED; HEALTH MAINTENANCE ORGANIZATIONS; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INPATIENTS; MINNESOTA; NEW YORK; OREGON; OUTPATIENTS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; SEASONS; TIME FACTORS;

EID: 0035884241     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/323085     Document Type: Article

References (27)

1. The impact of influenza epidemics on hospitalizations
2. The impact of influenza epidemics on mortality: Introducing a severity index
3. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
4. Behavioral risk factor surveillance system online prevalence data
5. Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations - United States, 1996
6. Association of influenza immunization with reduction in mortality in an elderly population: A prospective study
7. Influenza vaccination of elderly persons: Reduction in pneumonia and influenza hospitalizations and deaths
8. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community
9. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens
10. Clinical effectiveness of influenza vaccination in Manitoba
11. Nursing home outbreak of influenza A (H3N2): Evaluation of vaccine efficacy and influenza case definitions
12. Effectiveness of influenza vaccine when given during an outbreak of influenza A/H3N2 in a nursing home
13. Association of influenza immunization with reduction in mortality in an elderly population: A prospective study
14. Efficacy of influenza vaccine in nursing homes: Reduction in illness and complications during an influenza A (H3N2) epidemic
15. The efficacy of influenza vaccination in elderly individuals: A randomized double-blind placebo-controlled trial
16. Surveillance for influenza, United States, 1994-95, 1995-96, and 1996-97 seasons
17. Update: Influenza activity - United States and worldwide, 1997-98 season, and composition of the 1998-99 influenza vaccine
18. Influenza vaccination programs for elderly persons: Cost-effectiveness in a health maintenance organization
19. Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly
20. Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons
21. Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic
22. Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database
23. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease
24. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic
25. The health and economic benefits of influenza vaccination for healthy and at-risk persons aged 65 to 74 years
26. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B